Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3916543 | Current Obstetrics & Gynaecology | 2006 | 8 Pages |
Abstract
SummaryWith advances in management, many women with sickle cell disease now survive to have children. The high risk of fetal and maternal sequelae mandates multidisciplinary management involving an obstetrician, a haematologist, an anaesthetist and a haemoglobinopathy specialist nurse. Hydroxyurea, a new treatment for sickle cell disease, is contraindicated in pregnancy. Exchange transfusion may be indicated in women with a serious obstetric or haematological complications. In those with sickle cell disease, the entire pregnancy is a high-risk period that warrants close monitoring. It is thus important for every obstetrician to be familiar with the condition.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Eugene Oteng-Ntim, Charlotte Cottee, Susan Bewley, Elizabeth N. Anionwu,